SO
Therapeutic Areas
Elanco Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Zenrelia (lotilaner) | Canine Atopic Dermatitis | Launched |
| Credelio | Flea & Tick Control | Marketed |
| Seresto | Flea & Tick Control | Marketed |
| Bovaer | Methane Reduction in Cattle | Launch |
| Next-Gen Parasiticides | Parasite Control | Discovery/Preclinical |
| Digital Pet Health Platform | Connected Care | Development |
| Poultry Vaccines | Poultry Diseases | Development/Registration |
| Aquaculture Therapeutics | Fish Diseases | Development/Registration |
Leadership Team at Elanco
JN
Jeffrey N. Simmons
President and Chief Executive Officer
TB
Tim Bettington
Executive Vice President, Center of Strategic Growth
ED
Ellen de Brabander, Ph.D.
Executive Vice President, Research, Development and Regulatory Affairs
DR
Dr. Ramiro M. Cabral
Executive Vice President, Elanco International
DK
David Kinard
Executive Vice President, Human Resources, Communications and Administration
GM
Grace McArdle
Executive Vice President, Manufacturing and Quality
R(
Rajeev (Bobby) Modi
Executive Vice President U.S. Pet Health and Global Digital Transformation
DJ
Dr. José Manuel Correia de Simas
Executive Vice President, U.S. Farm Animal Business
BV
Bob VanHimbergen
Executive Vice President and Chief Financial Officer